🇺🇸 FDA
Patent

US 9782472

Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity

granted A61KA61K38/162A61K39/12

Quick answer

US patent 9782472 (Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity) held by The Regents of the University of California expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/162, A61K39/12, A61K39/21, A61P